See with certainty Optain is an international MedTech company, developing advanced AI software solutions. Eyetelligence Assure software analyses full-colour fundus images to screen for referable eye diseases including glaucoma, diabetic retinopathy, and age-related macular degeneration. Additionally, the technology can screen for cardiovascular diseases and provide a risk assessment profile. Our vision is to harness the power of AI to provide affordable clinical support tools that make disease screening easy, anytime, anywhere.